Table 1 Patient Characteristics
From: Antifungal stewardship in a tertiary care paediatric hospital: the PROAFUNGI study
Total | |
|---|---|
Clinical characteristics, n | 55 |
• Age, y, median (IQR) | 8.7 (2.4–13.8) |
• Male sex, n (%) | 29 (53) |
Underlying disease | |
• Cancer, n (%) | 25 (45.5) |
• HSCT, n (%) | 15/25 (60) |
• Critical paediatric patients, n (%) | 14 (25.5) |
• Critical newborns, n (%) | 5 (9) |
• Primary immunodeficiencies, n (%) | 5 (9) |
• Solid organ transplant, n (%) | 3 (5.5) |
• Other, n (%) | 3 (5.5) |
Clinical situationa | |
• Risk of IFI, n (%) | 27 (49) |
• Suspicion of IFI, n (%) | 6 (11) |
• Possible IFI, n (%) | 14 (25) |
• Probable IFI, n (%) | 2 (4) |
• Proven IFI, n (%) | 6 (11) |
Microorganisms | |
• Candida spp. | 2/6 |
• Moulds | 4/6 |